Advertisement
Research Article| Volume 66, P121-125, January 2018

Download started.

Ok

Seroprevalence and risk factors of Hepatitis E infection in Jordan’s population: First report

Open AccessPublished:November 13, 2017DOI:https://doi.org/10.1016/j.ijid.2017.11.015

      Highlights

      • Seroprevalce, risk factors and zoonotic potential of HEV were studied.
      • HEV antibodies occurs at high prevalence (30.9%) overall in Jordan.
      • HEV infection associates with age and eating undercooked meat.
      • Owning camels increased the odds of HEV seropositivity.

      Abstract

      Objectives

      Hepatitis E virus (HEV) is hyperendemic in many countries, but data on this virus are not available in Jordan. This study determined the seroprevalence, risk factors and zoonotic potential of HEV in a Jordanian population.

      Methods

      A total of 450 sera samples from 8 different governorates were tested for HEV-IgG. A pre-tested and validated questionnaire was used to collect risk factor data including animal interaction and environmental exposures.

      Results

      The overall seroprevalence was 30.9%. Eating undercooked meat was significantly associated with HEV seropositivity (OR = 2.06, 95%CI 1.04–4.06) after controlling for age, gender, travel history and source of water. Age was also associated with HEV seropositivity; the youngest (≤14 years of age) and oldest age groups (60 and 80 years of age) had the highest prevalence (45.5% and 53.2%, respectively), compared to those between 20 to 29 years of age and 30 to 39 years of age (20.2 and 15.2%, respectively), although the small sample size among the youngest group tempers this association. There was evidence of a marginal association between owning camels and an increased odds of HEV seropositivity. Place of residence and source of drinking water were not associated with infection.

      Conclusion

      This is the first study to report HEV seroprevalence in Jordan and shows that HEV exposure is high in Jordan. Surveillance for acute and chronic Hepatitis E is needed to estimate the frequency of the actual disease.

      Keywords

      Introduction

      Hepatitis E virus (HEV) is a single-strand RNA virus classified in the genus Hepevirus, family Hepeviridae and can lead to acute disease with symptoms ranging from subclinical (where patients clear the virus rapidly) to fulminant hepatitis (symptoms can include fever, anorexia, vomiting, nausea, myalgia and jaundice) (
      • Teo C.G.
      Much meat, much malady: changing perceptions of the epidemiology of hepatitis E.
      ,
      • Yugo D.M.
      • Meng X.J.
      Hepatitis E virus: foodborne, waterborne and zoonotic transmission.
      ). To date, five genotypes (HEV-1 through HEV-4 and HEV-7) have been found in humans (
      • Aggarwal R.
      • Gandhi S.
      The global prevalence of hepatitis E virus infection and susceptibility: a systematic review.
      ,
      • Lee G.H.
      • Tan B.H.
      • Teo E.C.
      • Lim S.G.
      • Dan Y.Y.
      • Wee A.
      • et al.
      Chronic infection with camelid Hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk.
      ). HEV-1 and HEV-2 primarily infect humans via the fecal-oral route and have been the main source of large waterborne HEV outbreaks in low- and middle-income countries (LMICs) (
      • Dalton H.R.
      • Bendall R.
      • Ijaz S.
      • Banks M.
      Hepatitis E: an emerging infection in developed countries.
      ,
      • Mirazo S.
      • Ramos N.
      • Mainardi V.
      • Gerona S.
      • Arbiza J.
      Transmission, diagnosis, and management of hepatitis E: an update.
      ). HEV-3 (in Europe and United States) and HEV-4 (in China, Japan and Southern Europe) outbreaks in humans have been associated with zoonotic exposure, including pork product consumption and handling (
      • Chalupa P.
      • Vasickova P.
      • Pavlik I.
      • Holub M.
      Endemic hepatitis E in the Czech Republic.
      ,
      • Dalton H.R.
      • Bendall R.
      • Ijaz S.
      • Banks M.
      Hepatitis E: an emerging infection in developed countries.
      ,
      • Dalton H.R.
      • Kamar N.
      • Izopet J.
      Hepatitis E in developed countries: current status and future perspectives.
      ,
      • Krumbholz A.
      • Mohn U.
      • Lange J.
      • Motz M.
      • Wenzel J.J.
      • Jilg W.
      • et al.
      Prevalence of hepatitis E virus-specific antibodies in humans with occupational exposure to pigs.
      ,
      • Krumbholz A.
      • Joel S.
      • Dremsek P.
      • Neubert A.
      • Johne R.
      • Durrwald R.
      • et al.
      Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany.
      ,
      • Romanò L.
      • Paladini S.
      • Tagliacarne C.
      • Canuti M.
      • Bianchi S.
      • Zanetti A.R.
      hepatitis E in Italy: a long-term prospective study.
      ,
      • Wichmann O.
      • Schimanski S.
      • Koch J.
      • Kohler M.
      • Rothe C.
      • Plentz A.
      • et al.
      Phylogenetic and case-control study on hepatitis E virus infection in Germany.
      ). Moreover, recently, HEV-7 was reported in one person in the United Arab Emirates and was linked to consumption of camel products (
      • Lee G.H.
      • Tan B.H.
      • Teo E.C.
      • Lim S.G.
      • Dan Y.Y.
      • Wee A.
      • et al.
      Chronic infection with camelid Hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk.
      ).
      HEV has been identified in the environment and in food, including in untreated water, shellfish, produce, and meat (
      • Teo C.G.
      Much meat, much malady: changing perceptions of the epidemiology of hepatitis E.
      ,
      • Yugo D.M.
      • Meng X.J.
      Hepatitis E virus: foodborne, waterborne and zoonotic transmission.
      ). In addition, HEV has been detected in swine in the US, Japan, Madagascar, and several European countries such as Spain, Germany and the Netherlands (
      • Grierson S.
      • Heaney J.
      • Cheney T.
      • Morgan D.
      • Wyllie S.
      • Powell L.
      • et al.
      Prevalence of Hepatitis E virus infection in pigs at the time of slaughter, United Kingdom, 2013.
      ,
      • Huang F.
      • Haqshenas G.
      • Guenette D.
      • Halbur P.
      • Schommer S.
      • Pierson F.
      • et al.
      Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the United States.
      ,
      • Oliveira-Filho E.F.
      • Bank-Wolf B.R.
      • Thiel H.-J.
      • König M.
      Phylogenetic analysis of hepatitis E virus in domestic swine and wild boar in Germany.
      ,
      • Primadharsini P.P.
      • Miyake M.
      • Kunita S.
      • Nishizawa T.
      • Takahashi M.
      • Nagashima S.
      • et al.
      Full-length genome of a novel genotype 3 hepatitis E virus strain obtained from domestic pigs in Japan.
      ,
      • Rutjes S.A.
      • Lodder W.J.
      • Lodder-Verschoor F.
      • van den Berg H.H.
      • Vennema H.
      • Duizer E.
      • et al.
      Sources of hepatitis E virus genotype 3 in The Netherlands.
      ,
      • Seminati C.
      • Mateu E.
      • Peralta B.
      • de Deus N.
      • Martin M.
      Distribution of hepatitis E virus infection and its prevalence in pigs on commercial farms in Spain.
      ,
      • Temmam S.
      • Besnard L.
      • Andriamandimby S.F.
      • Foray C.
      • Rasamoelina-Andriamanivo H.
      • Héraud J.M.
      • et al.
      High prevalence of hepatitis E in humans and pigs and evidence of genotype-3 virus in swine, Madagascar.
      ). Although the virus has not been isolated from ruminants, serological studies in the United States, Egypt, India, China and Spain have detected anti-HEV antibodies in these animals (
      • Arankalle V.A.
      • Joshi M.V.
      • Kulkarni A.M.
      • Gandhe S.S.
      • Chobe L.P.
      • Rautmare S.S.
      • et al.
      Prevalence of anti-hepatitis E virus antibodies in different Indian animal species.
      ,
      • El-Tras W.F.
      • Tayel A.A.
      • El-Kady N.N.
      Seroprevalence of hepatitis E virus in humans and geographically matched food animals in Egypt.
      ,
      • Peralta B.
      • Casas M.
      • de Deus N.
      • Martín M.
      • Ortuño A.
      • Pérez-Martín E.
      • et al.
      Anti-HEV antibodies in domestic animal species and rodents from Spain using a genotype 3-based ELISA.
      ,
      • Sanford B.J.
      • Emerson S.U.
      • Purcell R.H.
      • Engle R.E.
      • Dryman B.A.
      • Cecere T.E.
      • et al.
      Serological evidence for a hepatitis e virus-related agent in goats in the United States.
      ,
      • Yan B.
      • Zhang L.
      • Gong L.
      • Lv J.
      • Feng Y.
      • Liu J.
      • et al.
      Hepatitis E virus in yellow cattle, Shandong, Eastern China.
      ). In addition, HEV-7 has recently been isolated from dromedary camels in North and East Africa, UAE and Pakistan (
      • Rasche A.
      • Saqib M.
      • Liljander A.M.
      • Bornstein S.
      • Zohaib A.
      • Renneker S.
      • et al.
      Hepatitis E virus infection in dromedaries, North and East Africa, United Arab Emirates, and Pakistan, 1983–2015.
      ,
      • Woo P.C.
      • Lau S.K.
      • Teng J.L.
      • Tsang A.K.
      • Joseph M.
      • Wong E.Y.
      • et al.
      New hepatitis E virus genotype in camels, the Middle East.
      ).
      Sporadic cases and clusters of hepatitis E have been reported with increasing frequency in several European countries including the United Kingdom, Denmark, Spain, France, the Netherlands, Hungary, Germany and Norway (
      • Lewis H.C.
      • Wichmann O.
      • Duizer E.
      Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review.
      ). In contrast, HEV is considered hyperendemic in several LMICs including Egypt, China, Bangladesh, India and Mexico (
      • Teo C.G.
      Much meat, much malady: changing perceptions of the epidemiology of hepatitis E.
      ) with HEV epidemics also described elsewhere in the Middle East and North Africa (MENA) (Algeria, Libya, Morocco, Israel and Turkey) (
      • Aggarwal R.
      • Gandhi S.
      The global prevalence of hepatitis E virus infection and susceptibility: a systematic review.
      ,
      • Erez-Granat O.
      • Lachish T.
      • Daudi N.
      • Shouval D.
      • Schwartz E.
      Hepatitis E in Israel: a nation-wide retrospective study.
      ). In MENA, hepatitis E accounts for a variable proportion (20–60%) of acute hepatitis cases, and seroprevalence of anti-HEV antibodies has been up to 20%, with Egypt reporting up to 80% (
      • Aggarwal R.
      • Gandhi S.
      The global prevalence of hepatitis E virus infection and susceptibility: a systematic review.
      ). Despite the growing global threat of HEV, its existence in neighboring countries and the possible link to animal and environmental exposures, the epidemiology of HEV and risk factors remain unknown in Jordan. Thus, this study aimed to explore the seroprevalence of anti-HEV antibodies and associated risk factors in Jordan.

      Materials and methods

      Study design and population

      Jordan is an upper middle-income country located in the MENA region with a population of 7.6 million, and a life expectancy of 74 years (
      • World Bank
      Jordan: Country at a Glance World Bank.
      ). For this cross-sectional study we analyzed 450 blood samples collected during a cross-sectional zoonotic disease study conducted in Jordan between November 2015 to May 2016 (the parent study).

      Setting

      Between two to six governmental health centers per each of the eight governorates were included in the study. Centers were selected randomly from the Ministry of Health directory. All blood samples were collected by registered nurses and medical professionals. Sera were stored at the health care centers at −20 °C until shipment to the Food Safety and Zoonotic Diseases Laboratory at Jordan University of Science and Technology (JUST).

      Participants

      In Jordan, patients are often accompanied by their relatives to medical examinations and testing. Registered nurses or medical professionals approached every relative during their visit to the health centers’ laboratory for participation in the study. All participants were briefed about the study objectives and the voluntary nature of the study.

      Risk factors data collection

      A pre-tested and validated questionnaire written in Arabic was developed to collect demographic and risk factor data including food consumption habits, travel history and animal exposure. The questionnaire was pretested among 20 participating and 20 non-participating individuals and revisions were made on the final questionnaire. The questionnaire was self-administered.

      Sample size

      Since there were no data on the prevalence of HEV in Jordan, we calculated a sample size based on a prevalence rate of 50% (requiring the largest sample size) and with a precision of 5%. The minimum required sample size needed was 384, and we tested 450 samples. The tested samples were randomly selected from the serabank to avoid any bias.

      Ethical considerations

      The Institutional Research Bioethics Committee of JUST granted approval for this study (IRB policy # 7601). Samples collection was also approved by the IRB committee of the Jordanian Ministry of Health to allow access the governmental health center. Signed informed consent for all adult participants and parental consent for children were obtained before collecting data. No names or other identifiers were collected. Data were available to the research team only.

      Laboratory tests

      Sera were analyzed using HEV-IgG ELISA and the results were interpreted according to the manufacturer’s instructions. This ELISA kit (Fortress Diagnostics) employs a solid phase, indirect ELISA method and uses a long recombinant protein (PE2) of a Chinese strain that belongs to genotype 1. The sensitivity of this kit was 95% in samples from patients with PCR-confirmed HEV infection (
      • Schnegg A.
      • Burgisser P.
      • Andre C.
      • Kenfak-Foguena A.
      • Canellini G.
      • Moradpour D.
      • et al.
      An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population.
      ). The kit is identical to the Wantai assay, which is widely used in HEV seroprevalence studies (Beijing Wantai Biological Pharmacy Enterprise Co., Ltd, Beijing, China) (
      • Bendall R.
      • Ellis V.
      • Ijaz S.
      • Ali R.
      • Dalton H.
      A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries.
      ,
      • Bura M.
      • Lagiedo M.
      • Michalak M.
      • Sikora J.
      • Mozer-Lisewska I.
      Hepatitis E virus IgG seroprevalence in HIV patients and blood donors, west-central Poland.
      ,
      • Nasrallah G.K.
      • Al Absi E.S.
      • Ghandour R.
      • Ali N.H.
      • Taleb S.
      • Hedaya L.
      • et al.
      Seroprevalence of hepatitis E virus among blood donors in Qatar (2013–2016).
      ,
      • Sommerkorn F.M.
      • Schauer B.
      • Schreiner T.
      • Fickenscher H.
      • Krumbholz A.
      Performance of hepatitis E virus (HEV)-antibody tests: a comparative analysis based on samples from individuals with direct contact to domestic pigs or wild boar in Germany.
      ,
      • Wang L.
      • Geng J.
      Acute hepatitis E virus infection in patients with acute liver failure in China: not quite an uncommon cause.
      ,
      • Wenzel J.J.
      • Preiss J.
      • Schemmerer M.
      • Huber B.
      • Jilg W.
      Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates.
      ). The specificity for the Wantai ELISA was evaluated in 9000 individuals and was 98.6% according to the package insert. The test results of each plate were validated separately by verifying the quality control criteria as described by the manufacturer.

      Statistical analysis

      The test results and questionnaire data were entered into Microsoft Excel and analyzed using Stata version 12.1 (StataCorp LLC, College Station, TX, USA). Frequency distributions were examined to assess the distribution of the data. Simple descriptive statistics, χ2 and t-test statistics were performed where appropriate. Bivariate analyses were conducted to assess associations between HEV seropositivity and independent variables collected (gender, age, education, occupation, rural or urban residence, type of house, animal exposure, travel history, consumption of raw meats or milk). Variables associated with the outcome at a p-value of 0.05 or less and variables reported in the literature to be important were included in the final model.

      Results

      Table 1 shows the distribution of hepatitis E virus (HEV) seropositivity across the main independent variables. Overall 30.9% of individuals sampled were positive for HEV antibodies and this did not differ by region (Figure 1). HEV seroprevalence was higher among males at 35.5% compared to females but this was not statistically significant. Seroprevalence varied by age group; the oldest age groups (those between 60 and 80 years of age) had the highest prevalence (53.2%), while those between 20 to 29 years of age and 30 to 39 years of age had significantly lower HEV seropositivity in comparison (20.2 and 15.2%, respectively). Although the sample size was small (n = 11), the youngest participants had a significantly higher seroprevelance at 45.5% compared to those 20 to 39 years of age. Table 1 also shows unadjusted (univariate analysis) and adjusted odds ratios (multivariate analysis) for being HEV seropositive. In the univariate analysis individuals with any education had a significantly lower odds of HEV seroprevalence compared with those who had no education (UOR = 0.51, p = 0.003), while those who had ever lived abroad had a significantly greater odds of being HEV seropositive (UOR = 1.79, p = 0.04) but these associations were not significant in the multivariate analysis. Eating undercooked meat was significantly associated with HEV seropositivity in both the univariate and multivariate analysis (AOR = 2.06, 95%CI 1.04–4.06 for the latter). Water source was not significantly associated with the outcome in both the univariate and multivariate analyses.
      Table 1Prevalence of anti-Hepatitis E IgG, unadjusted and adjusted odds ratios (OR) for HEV in Jordan, 2015–2016.
      Denominator was 450 unless otherwise noted.
      No. HEV+/No. tested% PositiveUnadjusted ORp-valueAdjusted OR (95% CI)
      Seropositive139/45030.89
      Age, continuous, years37.5NA1.03<0.0001.02 (1.01–1.04)
      Age
      <155/1145.52.150.27NA
      15–1912/4327.91NANA
      20–2925/12420.20.650.29NA
      30–3910/6615.20.460.11NA
      40–4931/97321.210.63NA
      50–5931/62502.580.03NA
      60–8025/4753.22.940.02NA
      Female67/24727.11NA1
      Male72/20335.51.480.061.32 (0.86–2.01)
      Rural residence79/25131.51NANA
      Urban residence60/19930.20.940.76NA
      Lives in an apartment50/15033.31NANA
      Lives in a house89/30029.70.840.43NA
      No education49/11741.91NANA
      Any education90/33327.00.510.0030.64 (0.39-1.03)
      Household Income
      Less than 750 USD98/31231.41NANA
      More than 750 USD41/13829.70.920.72NA
      Travel history
      Never lived abroad114/39129.21NANA
      Ever lived abroad25/5942.41.790.041.53 (0.85–2.78)
      Water source
      Water sources were not mutually exclusive, some respondents named 2 water sources. The reference group is any other water source.
      Rain collection cistern15/4731.91.050.87NA
      Filtered water78/26429.550.860.46NA
      Municipality Water53/16232.71.140.53NA
      Spring lakes8/1650.02.310.101.25 (0.42–3.71)
      Eat undercooked meat
      Compared to not eating undercooked meat.
      21/4447.72.230.012.06 (1.04–4.06)
      Drinks raw milk
      Compared to not drinking raw milk.
      20/5238.51.460.22NA
      Eat traditional wild herbs
      Compared to not eating traditional wild herbs.
      86/25933.21.290.22NA
      a Denominator was 450 unless otherwise noted.
      b Water sources were not mutually exclusive, some respondents named 2 water sources. The reference group is any other water source.
      c Compared to not eating undercooked meat.
      d Compared to not drinking raw milk.
      e Compared to not eating traditional wild herbs.
      Figure 1
      Figure 1Number of anti-hepatitis E IgG positive samples/total number of tested samples by region in Jordan, 2015–2016.
      Table 2 presents the unadjusted odds ratios between ownership of animals and growing vegetables and other related variables. Owning camels was associated with a greater odds of HEV seropositivity (UOR = 3.04, p = 0.15) although this was not significant. None of the other variables were associated with HEV seropositivity.
      Table 2Zoonotic and environmental risk factors for anti-Hepatitis E IgG seropositivity and unadjusted odds ratios, Jordan, 2015–2016.
      Animal ownershipNo. HEV+/No. tested% PositiveUnadjusted ORp-value
      Camels
       No135/44330.471
       Yes4/757.143.040.15
      Goat
       No118/38430.731
       Yes21/6532.31.080.80
      Cow
       No137/44031.141
       Yes2/10200.550.46
      Sheep
       No125/39331.811
       Yes14/5724.60.700.27
      Ruminant
       No116/37131.271
       Yes23/7929.10.900.71
      Cats
       No127/41630.531
       Yes11/3333.31.140.74
      Dogs
       No130/41631.251
       Yes9/3426.50.790.56
      Has Garden
       No82/25132.671
       Yes57/19928.60.830.34
      Grow vegetable
       No102/31032.91
       Yes37/13926.60.740.18
      Practice Agriculture
       No98/31531.11
       Yes41/13530.40.970.88

      Discussion

      This study of HEV seroprevalence in Jordan found that 30.9% of those sampled were positive. High seroprevalence was reported in Nepal (47.1%), Bangladesh (49.8%) and Southwest France (34.0%) (
      • Izopet J.
      • Labrique A.B.
      • Basnyat B.
      • Dalton H.R.
      • Kmush B.
      • Heaney C.D.
      • et al.
      Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France.
      ). High seroprevalence was also reported in the general population of France (31.9%), the Netherlands (27.0%), Switzerland (21.2%), Germany (29.5%) and Denmark (19.8%), meanwhile less than 15% seroprevalence was reported in Austria, UK, Italy and Czech Republic (
      • Hartl J.
      • Otto B.
      • Madden R.G.
      • Webb G.
      • Woolson K.L.
      • Kriston L.
      • et al.
      Hepatitis E seroprevalence in Europe: a meta-analysis.
      ). All of these reported seroprevalence studies used the Wantai test. In addition to being the first such study in Jordan, this study has several other important characteristics; it includes data on animal and environmental exposures and sampled individuals throughout Jordan.
      In the univariate analysis, males had greater odds of HEV seropositivity but this was not significant in the multivariate analysis. Several recent studies reported no differences in infection rates by gender (
      • Taha T.E.
      • Rusie L.K.
      • Labrique A.
      • Nyirenda M.
      • Soko D.
      • Kamanga M.
      • et al.
      Seroprevalence for hepatitis E and other viral hepatitides among diverse populations, Malawi.
      ). However, there is evidence that HEV-1 and HEV-2 affect women, particularly pregnant women, more severely than men (
      • Aggarwal R.
      • Gandhi S.
      The global prevalence of hepatitis E virus infection and susceptibility: a systematic review.
      ,
      • Kamar N.
      • Dalton H.R.
      • Abravanel F.
      • Izopet J.
      Hepatitis E virus infection.
      ). Statistically significant differences were observed between HEV seropositivity and age in both the univariate and multivariate analyses. When including age as a continuous variable in the model, the odds of HEV seropositivity are significantly greater. However, categorizing age unmasks that the youngest (those 6–14 years of age inclusive) and older age groups (50–80 years inclusive) had significantly greater odds of HEV seropositivity compared to those 15–19 years old. Several studies reported an increased odds of HEV seropositivity with increasing age (
      • Kuniholm M.H.
      • Labrique A.B.
      • Nelson K.E.
      Should HIV-infected patients with unexplained chronic liver enzyme elevations be tested for hepatitis E virus?.
      ), however most do not include children. The studies that have included children found lower HEV seroprevalence, with few exceptions in India and Egypt, that increased with age (
      • Krumbholz A.
      • Neubert A.
      • Joel S.
      • Girschick H.
      • Huppertz H.I.
      • Kaiser P.
      • et al.
      Prevalence of hepatitis E virus antibodies in children in Germany.
      ,
      • Verghese V.P.
      • Robinson J.L.
      A systematic review of hepatitis E virus infection in children.
      ). We found a high prevalence of HEV seroprevalence among children between 6 to 14 years of age (the youngest positive child was 10 years of age). However, our results should be interpreted with caution since there were only 11 participants in the youngest age group. The steady increase in seroprevalence among participants between 15 to 80 years of age is generally consistent with previous research (
      • Bura M.
      • Lagiedo M.
      • Michalak M.
      • Sikora J.
      • Mozer-Lisewska I.
      Hepatitis E virus IgG seroprevalence in HIV patients and blood donors, west-central Poland.
      ,
      • Verghese V.P.
      • Robinson J.L.
      A systematic review of hepatitis E virus infection in children.
      ). More research is needed to better understand the implications of HEV seropositivity over the lifespan and its relationship to multiple exposures and infection events.
      We report that eating undercooked meat appears to be significantly associated with an increased odds of HEV seropositivity (OR = 2.06, 95% CI 1.04–4.06). Previous studies have found a similar association (
      • Kuniholm M.H.
      • Labrique A.B.
      • Nelson K.E.
      Should HIV-infected patients with unexplained chronic liver enzyme elevations be tested for hepatitis E virus?.
      ,
      • Pavio N.
      • Merbah T.
      • Thebault A.
      Frequent hepatitis E virus contamination in food containing raw pork liver, France.
      ,
      • Pavio N.
      • Laval M.
      • Maestrini O.
      • Casabianca F.
      • Charrier F.
      • Jori F.
      Possible foodborne transmission of hepatitis E virus from domestic pigs and wild boars from Corsica.
      ). Future studies that capture detailed dietary history are recommended to identify food-borne risks. We also examined the association between animal ownership and HEV seropositivity and found that owning camels is associated with an increased odds of HEV seropositivity. Although this was not statistically significant and the number of participants who owned camels was small (n = 7), it does warrant further investigation in light of the recent discovery of HEV-7 (
      • Woo P.C.
      • Lau S.K.
      • Teng J.L.
      • Tsang A.K.
      • Joseph M.
      • Wong E.Y.
      • et al.
      New hepatitis E virus genotype in camels, the Middle East.
      ) in a patient that had a history of consuming camel meat and milk (
      • Lee G.H.
      • Tan B.H.
      • Teo E.C.
      • Lim S.G.
      • Dan Y.Y.
      • Wee A.
      • et al.
      Chronic infection with camelid Hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk.
      ) and in dromedaries (
      • Rasche A.
      • Saqib M.
      • Liljander A.M.
      • Bornstein S.
      • Zohaib A.
      • Renneker S.
      • et al.
      Hepatitis E virus infection in dromedaries, North and East Africa, United Arab Emirates, and Pakistan, 1983–2015.
      ).
      Additionally, the cross-sectional nature of this data limits the interpretation of the results since only associations are reported. Despite these, this study is useful for providing a first look into this epidemiology of HEV in Jordan. Genotyping studies are important to better understand the epidemiology of HEV in Jordan, and a detailed history of environmental and animal exposures are also needed.

      Conflict of interest

      We declare no competing interests.

      Acknowledgments

      This research was supported by the Deanship of Research at Jordan University of Science and Technology. We acknowledge Alaa E. Bani Salman for her support in implementing this study.

      References

        • Aggarwal R.
        • Gandhi S.
        The global prevalence of hepatitis E virus infection and susceptibility: a systematic review.
        World Health Organization, Geneva 27, Switzerland2010
        • Arankalle V.A.
        • Joshi M.V.
        • Kulkarni A.M.
        • Gandhe S.S.
        • Chobe L.P.
        • Rautmare S.S.
        • et al.
        Prevalence of anti-hepatitis E virus antibodies in different Indian animal species.
        J Viral Hepat. 2001; 8: 223-227
        • Bendall R.
        • Ellis V.
        • Ijaz S.
        • Ali R.
        • Dalton H.
        A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries.
        J Med Virol. 2010; 82: 799-805
        • Bura M.
        • Lagiedo M.
        • Michalak M.
        • Sikora J.
        • Mozer-Lisewska I.
        Hepatitis E virus IgG seroprevalence in HIV patients and blood donors, west-central Poland.
        Int J Infect Dis. 2017; 61: 20-22
        • Chalupa P.
        • Vasickova P.
        • Pavlik I.
        • Holub M.
        Endemic hepatitis E in the Czech Republic.
        Clin Infect Dis. 2014; 58: 509-516
        • El-Tras W.F.
        • Tayel A.A.
        • El-Kady N.N.
        Seroprevalence of hepatitis E virus in humans and geographically matched food animals in Egypt.
        Zoonoses Public Health. 2013; 60: 244-251
        • Erez-Granat O.
        • Lachish T.
        • Daudi N.
        • Shouval D.
        • Schwartz E.
        Hepatitis E in Israel: a nation-wide retrospective study.
        World J Gastroenterol. 2016; 22: 5568-5577
        • Dalton H.R.
        • Bendall R.
        • Ijaz S.
        • Banks M.
        Hepatitis E: an emerging infection in developed countries.
        Lancet Infect Dis. 2008; 8: 698-709
        • Dalton H.R.
        • Kamar N.
        • Izopet J.
        Hepatitis E in developed countries: current status and future perspectives.
        Future Microbiol. 2014; 9: 1361-1372
        • Grierson S.
        • Heaney J.
        • Cheney T.
        • Morgan D.
        • Wyllie S.
        • Powell L.
        • et al.
        Prevalence of Hepatitis E virus infection in pigs at the time of slaughter, United Kingdom, 2013.
        Emerging Infect Dis. 2015; 21: 1396-1401
        • Hartl J.
        • Otto B.
        • Madden R.G.
        • Webb G.
        • Woolson K.L.
        • Kriston L.
        • et al.
        Hepatitis E seroprevalence in Europe: a meta-analysis.
        Viruses. 2016; 8: 211https://doi.org/10.3390/v8080211
        • Huang F.
        • Haqshenas G.
        • Guenette D.
        • Halbur P.
        • Schommer S.
        • Pierson F.
        • et al.
        Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the United States.
        J Clin Microbiol. 2002; 40: 1326-1332
        • Izopet J.
        • Labrique A.B.
        • Basnyat B.
        • Dalton H.R.
        • Kmush B.
        • Heaney C.D.
        • et al.
        Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France.
        J Clin Virol. 2015; 70: 39-42
        • Kamar N.
        • Dalton H.R.
        • Abravanel F.
        • Izopet J.
        Hepatitis E virus infection.
        Clin Microbiol Rev. 2014; 27: 116-138
        • Kuniholm M.H.
        • Labrique A.B.
        • Nelson K.E.
        Should HIV-infected patients with unexplained chronic liver enzyme elevations be tested for hepatitis E virus?.
        Clin Infect Dis. 2010; 50: 1545-1546
        • Krumbholz A.
        • Mohn U.
        • Lange J.
        • Motz M.
        • Wenzel J.J.
        • Jilg W.
        • et al.
        Prevalence of hepatitis E virus-specific antibodies in humans with occupational exposure to pigs.
        Med Microbiol Immunol. 2012; 201: 239-244
        • Krumbholz A.
        • Joel S.
        • Dremsek P.
        • Neubert A.
        • Johne R.
        • Durrwald R.
        • et al.
        Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany.
        Med Microbiol Immunol. 2014; 203: 273-282
        • Krumbholz A.
        • Neubert A.
        • Joel S.
        • Girschick H.
        • Huppertz H.I.
        • Kaiser P.
        • et al.
        Prevalence of hepatitis E virus antibodies in children in Germany.
        Pediatr Infect Dis J. 2014; 33: 258-262
        • Lee G.H.
        • Tan B.H.
        • Teo E.C.
        • Lim S.G.
        • Dan Y.Y.
        • Wee A.
        • et al.
        Chronic infection with camelid Hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk.
        Gastroenterology. 2016; 150 (e3): 355-357
        • Lewis H.C.
        • Wichmann O.
        • Duizer E.
        Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review.
        Epidemiol Infect. 2010; 138: 145-166
        • Nasrallah G.K.
        • Al Absi E.S.
        • Ghandour R.
        • Ali N.H.
        • Taleb S.
        • Hedaya L.
        • et al.
        Seroprevalence of hepatitis E virus among blood donors in Qatar (2013–2016).
        Transfusion. 2017; 57: 1801-1807
        • Mirazo S.
        • Ramos N.
        • Mainardi V.
        • Gerona S.
        • Arbiza J.
        Transmission, diagnosis, and management of hepatitis E: an update.
        Hepat Med. 2014; 6: 45-59
        • Oliveira-Filho E.F.
        • Bank-Wolf B.R.
        • Thiel H.-J.
        • König M.
        Phylogenetic analysis of hepatitis E virus in domestic swine and wild boar in Germany.
        Vet Microbiol. 2014; 174: 233-238
        • Pavio N.
        • Laval M.
        • Maestrini O.
        • Casabianca F.
        • Charrier F.
        • Jori F.
        Possible foodborne transmission of hepatitis E virus from domestic pigs and wild boars from Corsica.
        Emerg Infect Dis. 2016; 22: 2197-2199
        • Pavio N.
        • Merbah T.
        • Thebault A.
        Frequent hepatitis E virus contamination in food containing raw pork liver, France.
        Emerg Infect Dis. 2014; 20: 1925-1927
        • Peralta B.
        • Casas M.
        • de Deus N.
        • Martín M.
        • Ortuño A.
        • Pérez-Martín E.
        • et al.
        Anti-HEV antibodies in domestic animal species and rodents from Spain using a genotype 3-based ELISA.
        Vet Microbiol. 2009; 137: 66-73
        • Primadharsini P.P.
        • Miyake M.
        • Kunita S.
        • Nishizawa T.
        • Takahashi M.
        • Nagashima S.
        • et al.
        Full-length genome of a novel genotype 3 hepatitis E virus strain obtained from domestic pigs in Japan.
        Virus Res. 2017; 240: 147-153
        • Rasche A.
        • Saqib M.
        • Liljander A.M.
        • Bornstein S.
        • Zohaib A.
        • Renneker S.
        • et al.
        Hepatitis E virus infection in dromedaries, North and East Africa, United Arab Emirates, and Pakistan, 1983–2015.
        Emerg Infect Dis. 2016; 22: 1249-1252
        • Romanò L.
        • Paladini S.
        • Tagliacarne C.
        • Canuti M.
        • Bianchi S.
        • Zanetti A.R.
        hepatitis E in Italy: a long-term prospective study.
        J Hepatol. 2011; 54: 34-40
        • Rutjes S.A.
        • Lodder W.J.
        • Lodder-Verschoor F.
        • van den Berg H.H.
        • Vennema H.
        • Duizer E.
        • et al.
        Sources of hepatitis E virus genotype 3 in The Netherlands.
        Emerg Infect Dis. 2009; 15: 381-387
        • Sanford B.J.
        • Emerson S.U.
        • Purcell R.H.
        • Engle R.E.
        • Dryman B.A.
        • Cecere T.E.
        • et al.
        Serological evidence for a hepatitis e virus-related agent in goats in the United States.
        Transbound Emerg Dis. 2013; 60: 538-545
        • Schnegg A.
        • Burgisser P.
        • Andre C.
        • Kenfak-Foguena A.
        • Canellini G.
        • Moradpour D.
        • et al.
        An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population.
        PLoS One. 2013; 8e62980
        • Sommerkorn F.M.
        • Schauer B.
        • Schreiner T.
        • Fickenscher H.
        • Krumbholz A.
        Performance of hepatitis E virus (HEV)-antibody tests: a comparative analysis based on samples from individuals with direct contact to domestic pigs or wild boar in Germany.
        Med Microbiol Immunol. 2017; 206: 277-286
        • Seminati C.
        • Mateu E.
        • Peralta B.
        • de Deus N.
        • Martin M.
        Distribution of hepatitis E virus infection and its prevalence in pigs on commercial farms in Spain.
        Vet J. 2008; 175: 130-132
        • Taha T.E.
        • Rusie L.K.
        • Labrique A.
        • Nyirenda M.
        • Soko D.
        • Kamanga M.
        • et al.
        Seroprevalence for hepatitis E and other viral hepatitides among diverse populations, Malawi.
        Emerg Infect Dis. 2015; 21: 1174-1182
        • Temmam S.
        • Besnard L.
        • Andriamandimby S.F.
        • Foray C.
        • Rasamoelina-Andriamanivo H.
        • Héraud J.M.
        • et al.
        High prevalence of hepatitis E in humans and pigs and evidence of genotype-3 virus in swine, Madagascar.
        Am J Trop Med Hyg. 2013; 88: 329-338
        • Teo C.G.
        Much meat, much malady: changing perceptions of the epidemiology of hepatitis E.
        Clin Microbiol Infect. 2010; 16: 24-32
        • Verghese V.P.
        • Robinson J.L.
        A systematic review of hepatitis E virus infection in children.
        Clin Infect Dis. 2014; 59: 689-697
        • Wang L.
        • Geng J.
        Acute hepatitis E virus infection in patients with acute liver failure in China: not quite an uncommon cause.
        Hepatology. 2017; 65: 1769-1770
        • Wenzel J.J.
        • Preiss J.
        • Schemmerer M.
        • Huber B.
        • Jilg W.
        Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates.
        J Infect Dis. 2013; 207: 497-500
        • Wichmann O.
        • Schimanski S.
        • Koch J.
        • Kohler M.
        • Rothe C.
        • Plentz A.
        • et al.
        Phylogenetic and case-control study on hepatitis E virus infection in Germany.
        J Infect Dis. 2008; 198: 1732-1741
        • World Bank
        Jordan: Country at a Glance World Bank.
        2016
        • Woo P.C.
        • Lau S.K.
        • Teng J.L.
        • Tsang A.K.
        • Joseph M.
        • Wong E.Y.
        • et al.
        New hepatitis E virus genotype in camels, the Middle East.
        Emerg Infect Dis. 2014; 20: 1044-1048
        • Yan B.
        • Zhang L.
        • Gong L.
        • Lv J.
        • Feng Y.
        • Liu J.
        • et al.
        Hepatitis E virus in yellow cattle, Shandong, Eastern China.
        Emerg Infect Dise. 2016; 22: 2211-2212
        • Yugo D.M.
        • Meng X.J.
        Hepatitis E virus: foodborne, waterborne and zoonotic transmission.
        Int J Environ Res Public Health. 2013; 10: 4507-4533